Home › NCT02573753
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Only subjects who are eligible for ongoing IRB-approved studies will be deemed eligible for this protocol. Exclusion Criteria: * Pregnant or breast-feeding women * Subjects who are ineligible for ongoing IRB-approved studies will not be included in this protocol
About the study
The aggregate of microorganisms inhabiting the human body can be regarded as a dynamic reflector of both healthy and disease states, altering in response to changes in the environment. This may precede clinically detectable disease; and thereby, could be used to predict disease onset and additionally monitor response to treatment and predict prognosis. The primary hypothesis of this pilot study is that the human microbial communities are influenced by sleep and altered in humans with abnormal sleep patterns, and they may ultimately relate to disease risk.
What is being tested
- Sleep restriction (behavioral)
- Weight gain (dietary supplement)
Sponsor: Mayo Clinic · Participants: 5,000 · Started: 2015-10
Contact the study team
- Nick Wozniak · Phone: 507-255-8794
- Laura Hammel · Phone: 507-255-6676
Official record on ClinicalTrials.gov — NCT02573753
Locations in the U.S.
| Minnesota | Mayo Clinic Rochester, Rochester |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.